Clinical Trial Update: Efficacy and Safety of 3% Hypertonic Saline Inhalation (24h vs 72h) to Treat Acute Bronchiolitis in Hospitalized Infants [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the efficacy and safety of inhaled 3% hypertonic saline for acute bronchiolitis in hospitalized infants, comparing 24-hour vers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis

Drugs mentioned

• Hypertonic saline inhalation 3% (Sodium chloride 3% inhalation solution)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Bronchiolitis | Phase 4 | Status: COMPLETED